Skip to search formSkip to main contentSkip to account menu

rapacuronium

Known as: rapacuronium [Chemical/Ingredient] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Background:Neuromuscular blocking agents’ detrimental airway effects may occur as a result of interactions with muscarinic… 
Highly Cited
2003
Highly Cited
2003
Background A safe and effective ultra-short-acting nondepolarizing neuromuscular blocking agent is required to block nicotinic… 
Review
2002
Review
2002
We conducted this study to determine the risk factors for the development of bronchospasm after the administration of… 
2001
2001
IN December 2000, subscribers to the Paediatric Anaesthesia Conference discussion group were invited to post their experiences… 
2000
2000
The purpose of this nine-centre study in 602 patients was to show that the frequency of acceptable intubating conditions after… 
2000
2000
We studied the antagonism of rapacuronium with edrophonium-atropine during propofol- or sevoflurane- based anesthesia in 60… 
2000
2000
Background: The aim of this study was to determine the dose or doses of the new rapid-onset, short-acting, neuromuscular blocking… 
1999
1999
UNLABELLED Neuromuscular blocking drugs may have variable effects on heart rate (HR) and blood pressure. Rapacuronium is a rapid… 
1999
1999
UNLABELLED Rapacuronium (Org 9487) is a rapid-onset and short- to intermediate-acting muscle relaxant. Its 3-desacetyl metabolite… 
1999
1999
BACKGROUND Delayed elimination kinetics of steroidal neuromuscular blocking agents have been observed in patients with cirrhosis…